Health Care & Life Sciences » Biotechnology | XBiotech Inc.

XBiotech Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
7,244.00
57,329.00
91,051.00
34,324.00
31,768.00
15,823
Other Current Assets
449.00
411.00
1,990.00
2,606.00
1,564.00
1,193
Total Current Assets
7,693.00
57,740.00
93,041.00
36,930.00
33,332.00
17,016
Net Property, Plant & Equipment
3,380.00
4,113.00
16,317.00
30,120.00
29,640.00
27,329
Other Assets
-
324.00
-
-
-
-
Total Assets
11,073.00
62,177.00
109,358.00
67,050.00
62,972.00
44,345
Accounts Payable
-
-
-
-
1,730.00
Other Current Liabilities
845.00
3,147.00
6,291.00
7,963.00
1,062.00
Total Current Liabilities
845.00
3,147.00
6,291.00
7,963.00
2,792.00
Other Liabilities
-
-
17.00
23.00
18.00
Total Liabilities
845.00
3,147.00
6,308.00
7,986.00
2,810.00
Common Equity (Total)
10,228.00
59,030.00
103,050.00
59,064.00
60,162.00
Total Shareholders' Equity
10,228.00
59,030.00
103,050.00
59,064.00
60,162.00
Total Equity
10,228.00
59,030.00
103,050.00
59,064.00
60,162.00
Liabilities & Shareholders' Equity
11,073.00
62,177.00
109,358.00
67,050.00
62,972.00

About XBiotech

View Profile
Address
5217 Winnebago Lane
Austin Texas 78744
United States
Employees -
Website http://www.xbiotech.com
Updated 07/08/2019
XBiotech, Inc. is a biopharmaceutical company, which engages in discovering and developing True Human monoclonal antibodies for treating diseases. It offers MABp1, which targets and neutralizes interleukin-1 alpha, a molecule known to promote angiogenesis, growth and spread of tumors, as well as mediate symptoms such as metabolic dysregulation, fatigue, and anxiety associated with advanced cancer. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.